{"id":"https://openalex.org/W2410967397","doi":null,"title":"Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?","display_name":"Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2410967397","mag":"2410967397","pmid":"https://pubmed.ncbi.nlm.nih.gov/24615368"},"language":"en","primary_location":{"id":"pmid:24615368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24615368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064910237","display_name":"David F Blackburn","orcid":"https://orcid.org/0000-0002-7831-5913","observed_orcids":["https://orcid.org/0000-0002-7831-5913"]},"institutions":[{"id":"https://openalex.org/I32625721","display_name":"University of Saskatchewan","ror":"https://ror.org/010x8gc63","country_code":"CA","type":"education","lineage":["https://openalex.org/I32625721"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David F Blackburn","raw_affiliation_strings":["T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan","institution_ids":["https://openalex.org/I32625721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111538062","display_name":"David A. Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32625721","display_name":"University of Saskatchewan","ror":"https://ror.org/010x8gc63","country_code":"CA","type":"education","lineage":["https://openalex.org/I32625721"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David Tran","raw_affiliation_strings":["T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan","institution_ids":["https://openalex.org/I32625721"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alex Crawley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32625721","display_name":"University of Saskatchewan","ror":"https://ror.org/010x8gc63","country_code":"CA","type":"education","lineage":["https://openalex.org/I32625721"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alex Crawley","raw_affiliation_strings":["T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan","institution_ids":["https://openalex.org/I32625721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032853548","display_name":"Sarah Lynds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32625721","display_name":"University of Saskatchewan","ror":"https://ror.org/010x8gc63","country_code":"CA","type":"education","lineage":["https://openalex.org/I32625721"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sarah Lynds","raw_affiliation_strings":["T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"T he College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan","institution_ids":["https://openalex.org/I32625721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006496857","display_name":"Anne Champagne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799377091","display_name":"Saskatchewan Health","ror":"https://ror.org/05m2a2x14","country_code":"CA","type":"government","lineage":["https://openalex.org/I2799377091","https://openalex.org/I4210143365"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Anne Champagne","raw_affiliation_strings":["Drug Plan and Extended Benefits Branch, Saskatchewan Ministry of Health, Regina, Saskatchewan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Plan and Extended Benefits Branch, Saskatchewan Ministry of Health, Regina, Saskatchewan","institution_ids":["https://openalex.org/I2799377091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074091957","display_name":"Lauren C. Bresee","orcid":"https://orcid.org/0000-0002-4387-9612","observed_orcids":["https://orcid.org/0000-0002-4387-9612"]},"institutions":[{"id":"https://openalex.org/I126859394","display_name":"Alberta Health Services","ror":"https://ror.org/02nt5es71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I126859394"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lauren Bresee","raw_affiliation_strings":["Alberta Health Services, Calgary, Alberta, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Health Services, Calgary, Alberta, Canada;","institution_ids":["https://openalex.org/I126859394"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010489018","display_name":"Alfred J. R\u00e9millard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfred J Remillard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"1","first_page":"e31","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prior-authorization","display_name":"prior authorization","score":0.9330000281333923},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8989999890327454},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.8550000190734863},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.4950000047683716},{"id":"https://openalex.org/keywords/hospital-discharge","display_name":"hospital discharge","score":0.7459999918937683},{"id":"https://openalex.org/keywords/saskatchewan","display_name":"Saskatchewan","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8633047342300415},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8193129301071167},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.7887767553329468},{"id":"https://openalex.org/C2779598192","wikidata":"https://www.wikidata.org/wiki/Q17514788","display_name":"Prior authorization","level":2,"score":0.77099609375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.67254239320755},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.5638813376426697},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5347897410392761},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.45492663979530334},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4544832706451416},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4133714735507965},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38575130701065063},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.36782118678092957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17128172516822815},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.10643017292022705},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007349","descriptor_name":"Insurance, Health, Reimbursement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010351","descriptor_name":"Patient Discharge","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012525","descriptor_name":"Saskatchewan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24615368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24615368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","raw_type":"Comparative Study"},{"id":"mag:2410967397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24615368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1507718585","https://openalex.org/W1982995093","https://openalex.org/W2003613714","https://openalex.org/W2163977847","https://openalex.org/W2275784987"],"related_works":["https://openalex.org/W2025731152","https://openalex.org/W2207824447","https://openalex.org/W4281728275","https://openalex.org/W365806452","https://openalex.org/W2324237541","https://openalex.org/W2143357028","https://openalex.org/W1982995093","https://openalex.org/W2343547413","https://openalex.org/W7099556248","https://openalex.org/W2994743616"],"abstract_inverted_index":{"BACKGROUND:":[0],"Drug":[1],"benefit":[2],"providers":[3],"can":[4],"decrease":[5],"prescribing":[6,52,69,115,240],"of":[7,53,67,98,109,125,139,151,172,186,204,241,247],"specific":[8],"medications":[9],"through":[10],"prior":[11,31],"authorization":[12,32,74],"policies.":[13],"In":[14],"Saskatchewan,":[15,84,250],"certain":[16],"second":[17],"generation":[18],"antipsychotics":[19],"(SGAs)":[20],"are":[21],"recognized":[22],"as":[23,201],"first-line":[24,54,165,242],"agents":[25],"to":[26,43,58,113,122,133,192,197,218,223,237],"manage":[27],"schizophrenia;":[28],"but,":[29],"require":[30],"because":[33],"their":[34],"coverage":[35],"is":[36],"restricted":[37],"in":[38,56,72,83,194,199,225,249],"other":[39],"conditions.":[40],"We":[41],"aimed":[42],"determine":[44],"if":[45],"the":[46,134,160,208,245],"need":[47],"for":[48,117,164,181,211,232,244],"prior-authorization":[49,233],"substantially":[50,238],"diminishes":[51],"SGAs":[55,104,243],"comparison":[57,66],"unrestricted":[59],"agents.":[60],"OBJECTIVES:":[61],"To":[62],"conduct":[63],"an":[64],"ecological":[65],"SGA":[68,126,147,162,173,205],"with":[70,93],"changes":[71],"prior-":[73],"policies":[75],"between":[76,100],"1997":[77,101,155],"and":[78,102,119,130,156,167,196,213,220],"2005":[79],"using":[80],"health-administrative":[81],"databases":[82],"Canada.":[85,251],"METHOD:":[86],"Eligible":[87],"subjects":[88],"were":[89,111,128],"discharged":[90],"from":[91,216,221],"hospital":[92,152],"a":[94,182,202],"first-time":[95],"primary":[96],"diagnosis":[97],"schizophrenia":[99,248],"2005.":[103],"dispensed":[105],"within":[106,149],"7":[107],"days":[108],"discharge":[110],"used":[112],"estimate":[114],"preferences":[116],"olanzapine":[118,176,212],"quetiapine":[120,214],"relative":[121],"risperidone.":[123],"Percentages":[124],"use":[127,166,174,190],"age":[129],"sex":[131],"standardized":[132],"2000":[135],"cohort.":[136],"RESULTS:":[137],"Out":[138],"1,277":[140],"eligible":[141],"patients,":[142],"521":[143],"(41%)":[144],"received":[145],"564":[146],"dispensations":[148],"7-days":[150],"discharge.":[153],"Between":[154],"1998,":[157],"risperidone":[158],"was":[159],"only":[161],"covered":[163],"made":[168,177],"up":[169,178],"72.6%":[170],"(82/113)":[171],"while":[175],"27.4%":[179],"(31/113)":[180],"crude":[183],"preference":[184,209],"ratio":[185],"0.38":[187],"(27.4/72.6).":[188],"Risperidone":[189],"decreased":[191],"65.8%":[193],"1999-2002":[195],"47.4%":[198],"2003-2005":[200],"percentage":[203],"dispensations.":[206],"Correspondingly,":[207],"ratios":[210],"increased":[215],"0.40":[217],"0.57":[219],"0.12":[222],"0.54":[224],"these":[226],"respective":[227],"periods.":[228],"CONCLUSIONS:":[229],"The":[230],"requirement":[231],"does":[234],"not":[235],"appear":[236],"diminish":[239],"treatment":[246]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}